Skip to main content

Arthritis Research & Therapy: Celebrating 20 Successful Years

In 1999, Arthritis Research & Therapy launched in publication with the Editors-in-Chief, Sir Ravinder Maini and Peter Lipsky, leading the Editorial Board in pioneering the field of rheumatology. The journal  – named simply Arthritis Research at the time – made use of the internet as a new resource: a platform for sharing breakthrough discoveries, exchanging ideas and finding and connecting with colleagues interested in the science of musculoskeletal medicine. 

Today, Arthritis Research & Therapy covers the full range of autoimmune rheumatic diseases, publishing key studies and translational knowledge that has delivered stunning advances in clinical care. We're looking back at the milestone achievements and highlights that have made Arthritis Research & Therapy the field's leading open access journal, as it is today.

Check out our specially commissioned collection

Authors of our top cited Research articles look back at the way in which their articles have become so impactful. Read their Editorials here.

Our Milestones

(Click here to enlarge the infographic)

We invited our authors and editors to share their thoughts on Arthiritis and Research Therapy.

“I have been delighted to be associated with Arthritis Research and Therapy as an author, reviewer and associate editor. It has led the way for open access scientific publication in rheumatology and has really developed an enviable reputation for publishing high quality and relevant translational and laboratory research, as well as clinical papers. As the boundaries between mechanistic, translational and clinical research are increasingly overlapping this is more relevant than ever. 
Congratulations to the journal on a very successful first two decades.”

– Professor Chris Denton, UCL Division of Medicine, UK

“The initial publication of Arthritis Research & Therapy was a breath of fresh air in the rheumatological domain: a broader scope of research interests, in particular translational research, than the status quo journals of the time, as well as a faster reviewing and decision making process. The Editors who founded the journal were visionaries in their appreciation of where medical scientific publishing is heading and have helped to create the wider scientific base that all of us in rheumatology can now be proud of.”

– Professor Alexander So, CHUV, Switzerland

“I’ve enjoyed reading and publishing in Arthritis Research & Therapy for a number of reasons; the journal publishes a great diversity of content, including many articles about crystal arthritis, which is an under-emphasized area of rheumatology. The process for submission and publication is streamlined and efficient, and it’s great to have access to all the content through the open access model.”

– Professor Nicola Dalbeth, The University of Aukland, New Zealand

Our top ranked articles of the past 20 years




Use of NSAIDs in treating patients with arthritis by L.J. Crofford



Subchondral bone in osteoarthritis: insight into risk factors and
microstructural changes
 by G. Li et al.



Complement and systemic lupus erythematosus by M.J. Walport



Liver involvement in subjects with rheumatic disease by C. Selmi et al.



Remission in psoriatic arthritis: is it possible and how can it be predicted? 
by T.P. Saber et al



(Data above correct as of 30 Sep 19)

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    5.7 - 5-year Impact Factor
    1.501 - SNIP (Source Normalized Impact per Paper)
    1.592 - SJR (SCImago Journal Rank)

    2023 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    111 days submission to accept (Median)

    2023 Usage 
    1,885 Altmetric mentions